Dr Ming Soh
BPharm (Hons) PhD

Dr Ming Soh completed her Bachelor of Pharmacy (Hons 1) and PhD at the University of Sydney and the University of Queensland respectively. Her research focuses on elucidating the impact of mutations in ion channel genes in epilepsy using a combination of in-vivo (mouse and associated behaviour), in-vitro (mammalian cell lines) and electrophysiological (patch-clamp, two-electrode voltage clamp, electrocorticography, electrocardiogram) techniques. In 2021, she identified dysfunctional cardiac arrhythmia variants as biomarkers to predict the risk of sudden unexpected death in epilepsy (SUDEP). She is currently developing SUDEP animal models to understand the combined impact of seizures and heart dysfunction on SUDEP risk and to trial clinically-approved treatments that could improve long-term survival in patients with epilepsy.

Ming has co-supervised three honours students to completion, all of whom graduated with Class 1, and one with a departmental award. Outside of academic research, Ming is actively involved in various committees and has taken part in organising symposiums, workshops, events and drafting/judging of postgraduate policies, procedures, awards and budgets.

Key collaborators:

• Professor Samuel Berkovic – Epilepsy Research Centre
• Professor Ingrid Scheffer – Epilepsy Research Centre
• Professor Chris Semsarian – Centenary Institute
• Dr Richard Bagnall – Centenary Institute
• Professor Dave Coghill- University of Melbourne
• Professor Clive May – The Florey
• Associate Professor Yugeesh Lankadeva – The Florey
• Dr Lindsea Booth – The Florey